Welcome to our dedicated page for Wyndham Hotels & Resorts SEC filings (Ticker: WH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings for Wyndham Hotels & Resorts, Inc. (NYSE: WH) provide detailed, regulatory insight into the operations, governance and capital structure of what the company describes as the world's largest hotel franchising business by number of franchised properties. Through documents such as Form 10-K, Form 10-Q and Form 8-K, investors can review information on Wyndham’s approximately 8,300 hotels, 25 brands, global room count and focus on the economy and midscale segments of the lodging industry.
Current reports on Form 8-K highlight material events. Recent examples include:
- An 8-K dated October 22, 2025 furnishing the press release for quarterly results, which discusses system-wide room growth, development pipeline metrics, RevPAR trends, fee-related revenues, adjusted EBITDA and share repurchases and dividends.
- An 8-K dated October 16, 2025 describing a sixth amendment to the company’s credit agreement, extending the maturity and increasing the capacity of its revolving credit facility, with details on interest rate terms.
- An 8-K dated October 30, 2025 outlining a chief financial officer transition, including the departure of the prior CFO, the appointment of Kurt Albert as Interim CFO and the key terms of his employment letter and retention award.
- An 8-K dated November 13, 2025 reporting the appointment of Alexandra A. Jung to the Board of Directors and her committee assignments, along with the board’s independence determination.
Periodic reports such as Form 10-K and Form 10-Q, while not reproduced here, typically contain segment information, risk factors, discussion of the franchising model, descriptions of the brand portfolio, and financial statements that complement the metrics highlighted in earnings press releases. These filings also provide detail on Wyndham’s credit facilities, including the revolving credit agreement referenced in the October 2025 amendment.
On this page, Stock Titan surfaces Wyndham’s SEC filings as they are posted to EDGAR and pairs them with AI-generated summaries. These summaries are designed to highlight the most important elements of each document—such as changes in leadership, updates to debt agreements, development pipeline data, or shareholder return actions—without replacing the need to read the full filing. Users can quickly scan for items related to quarterly results, capital structure changes, governance updates and other disclosures that may be relevant when analyzing WH stock.
Wyndham Hotels & Resorts, Inc. (WH) Form 144 notice reports a proposed sale of common stock. The filing shows 26,603 shares offered through Merrill Lynch (Iselin, NJ) with an aggregate market value of $2,328,000.00 and an approximate sale date of 08/18/2025 on the NYSE. The shares were acquired on 02/25/2020 via a stock option, and the payment is recorded as a stock option exercise. The seller named in the filing is Geoffrey Ballotti, and the form includes a representation that no undisclosed material adverse information is known by the seller.
Wyndham Hotels & Resorts, Inc. (WH) Form 144 disclosure: This notice reports proposed and recent sales of the issuer's common stock by insider Geoffrey Ballotti. He plans to sell 26,603 shares through Merrill Lynch on 08/15/2025 with an aggregate market value reported as $2,354,787.08. The filing lists 76,356,247 shares outstanding. Ballotti acquired securities on 02/25/2020 via a stock option and the acquisition table shows 261,932 shares acquired. The form also discloses two recent sales during May 2025: 26,650 shares on 05/15/2025 for $2,305,307.00 and 26,724 shares on 05/16/2025 for $2,290,550.00. The filer affirms no undisclosed material adverse information.
Myra J. Biblowit, identified as a director of Wyndham Hotels & Resorts (WH), reported changes in beneficial ownership on Form 4. The filing records a transaction dated 08/08/2025 that the filer describes as a charitable contribution of 595 shares of Wyndham common stock to a donor-advised fund. After the reported transactions the reporting person is shown as beneficially owning 12,839 shares of common stock directly.
The Form 4 also discloses entries of 90,978 deferred stock units and 3,511 restricted stock units, each identified in the footnotes. The filing presents these items as reported holdings or disposals and does not provide purchase price or cash-proceeds detail in the disclosure provided here.
Director Pauline D.E. Richards reported routine equity compensation in a Form 4 for Wyndham Hotels & Resorts (WH) dated 25-Jul-2025. The filing shows:
- 370 common shares issued for the quarterly board retainer at an implied $92/share.
- 273 deferred stock units (DSUs) credited for quarterly dividends; each DSU converts 1-for-1 into common stock when the director leaves the board.
- 16,918 directly held common shares
- 61,408 DSUs
- 3,511 restricted stock units
Wyndham Hotels & Resorts (WH) – Form 4 filed 29 Jul 2025
Independent director Myra J. Biblowit disclosed two routine equity grants dated 25 Jul 2025:
- 353 common shares issued for quarterly board retainer at an indicated value of $92 per share, bringing her directly held common-stock position to 13,434 shares.
- 404 deferred stock units (DSUs) credited for dividend equivalents at the same $92 valuation. Total DSUs now equal 90,978; each converts into one share upon the director’s departure from the board.
- She also reports ownership of 3,511 restricted stock units.
No sales or derivative exercises occurred. The filing reflects standard non-cash director compensation rather than discretionary open-market buying, so monetary impact on WH is de-minimis. Nevertheless, continued accumulation, coupled with an absence of dispositions, modestly reinforces board-shareholder alignment.
On 07/25/2025 Wyndham Hotels & Resorts (WH) director Bruce B. Churchill acquired 483 deferred stock units (DSUs) through the company’s quarterly board retainer. Each DSU converts into one share of common stock after the director leaves the board. The grant was valued at $92.00 per unit, equating to roughly $44.5 thousand in equity. After the award, Churchill’s direct beneficial ownership increases to 26,618 shares/DSUs. A footnote also discloses 3,511 restricted stock units (RSUs) that remain outstanding but were not part of a new transaction.
No shares were sold, and no derivative securities were exercised. The filing reflects routine director compensation designed to align board incentives with shareholders rather than a discretionary open-market purchase. Consequently, the market impact is expected to be minimal.
Wyndham Hotels & Resorts (WH) – Form 4 filing, 29 Jul 2025. Director Mukul V. Deoras reported the issuance of 437 deferred stock units (DSUs) on 25 Jul 2025 at an assigned price of $92 per unit, representing quarterly board retainer fees plus accrued dividends. The DSUs convert 1-for-1 into common shares after the director leaves the Board.
Following the transaction, Deoras’ beneficial holdings stand at:
- 21,535 DSUs (direct ownership)
- 3,511 restricted stock units (RSUs)
- 3,791 common shares
Wyndham Hotels & Resorts (WH) – Form 4 insider activity: Director James E. Buckman reported an automatic acquisition (code “A”) of 885 deferred stock units (DSUs) on 25 Jul 2025. Footnote 1 clarifies the DSUs were issued in lieu of quarterly board retainer payments and dividends; each unit converts 1-for-1 into common shares upon Buckman’s departure from the board. The filing lists a reference price of $92 per share, implying stock-based compensation of roughly $81k.
Following the grant, Buckman’s direct beneficial holdings are:
- 90,472 DSUs (footnote 2)
- 3,511 restricted stock units (footnote 3)
- 9,307 common shares (footnote 4)
No derivative securities or dispositions were reported. The transaction modestly increases insider equity exposure but is routine board compensation rather than an open-market purchase. No impact on earnings, guidance, or capital structure is disclosed.